CD38 antibodies kill tumor cells through a number of mechanisms—antibody‐dependent cellular cytotoxicity (ADCC), antibody‐dependent cellular phagocytosis (ADCP), complement‐dependent cytotoxicity (CDC), direct apoptosis, enzymatic inhibition, and immunomodulation (Figure 3).42 The gene discussed is CD38; the disease is neoplasm.